Evidence map›Paper›PMID 36387184›Full record

ArticleFrontiers in oncology2022

A refractory liver metastatic solid pseudopapillary neoplasm pancreas harbored

Yu Shang, Yunkun Zhang, Evenki Pan, Peng Yang, Lingling Xu, Jinghua Sun

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yu ShangDepartment of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yunkun ZhangDepartment of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Evenki PanDepartment of Medical, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Peng YangDepartment of Medical, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Lingling XuDepartment of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Jinghua SunDepartment of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid pseudopapillary neoplasm (SPN) of the pancreas is rare relatively low-grade malignant neoplasm and metastasis rarely. Surgical resection is the primary treatment option for primary and metastatic lesions of SPN, and chemotherapy is often ineffective in non-operable SPNs. SPNs are characterized by the presence of somatic

Indexed as

celecoxibCTNNB1 mutationliver metastasispancreasSolid pseudopapillary neoplasm (SPN)

Identifiers

PMID36387184
PMCPMC9650638
OpenAlexW4307927229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.